Table 1.
Patient demographic and perioperative characteristics
| Characteristic | Group; mean (range)* | p value† | |
|---|---|---|---|
| RAPD | HLAPD | ||
| Patient, no. | 12 | 14 | |
| Age, yr | 71 (26–80) | 69 (49–88) | 0.95 |
| Sex, male:female, % | 50:50 | 78.6:21.4 | 0.31 |
| ASA score | 2 (2–3) | 2 (2–3) | 0.07 |
| Duration of surgery, min | 596.5 (509–799) | 592.5 (407–779) | 0.78 |
| Estimated blood loss, mL | 275 (50–1000) | 400 (100–4000) | 0.26 |
| Intraoperative blood transfusion, no. (%) | 1 (8.3) | 5 (35.7) | 0.05 |
| Total 7-day analgesic use, mg IV, mean ± SD | 142.599 ± 68.2 | 176.9 ± 112.7 | 0.35 |
| LOS, d | 7.5 (5–57) | 8 (6–14) | 0.78 |
| 90-day mortality, % | 0% | 7.1% | 0.14 |
ASA = American Society of Anaesthesiologists; HLAPD = hybrid laparoscopy-assisted pancreaticoduodenectomy; IV = intravenous; LOS = length of stay; RAPD = robotic-assisted pancreaticoduodenectomy; SD = standard deviation.
*
Unless indicated otherwise.
†
Mann–Whitney U test.